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Abstract
Background: A series of complications caused by enteroviruses, including meningitis, encephalitis, acute flaccid
paralysis, acute cardiopulmonary failure, respiratory infection, and myocardial injury have been reported in hand,
foot and mouth disease/herpangina (HFMD/HA). However, the complication of diarrhoea caused by enteroviruses
has been neglected, and a summary of its clinical features and impact on HFMD/HA is unavailable.
Methods: We included inpatients with HFMD/HA admitted to the Paediatric Department of Zhujiang Hospital
during 2009–2012. We summarised and compared clinical data for cases with and without diarrhoea, and
determined enterovirus serotypes by reverse transcriptase polymerase chain reaction and genotyping based
on a partial-length fragment of viral protein 1 or the 5’-untranslated region.
Results: There were 804 inpatients with HFMD/HA and 28 (3.5 %) presented with diarrhoea. Gastrointestinal
symptoms were mild in most cases of diarrhoea (82.1 %), with high prevalence of no dehydration (82.1 %),
short duration of diarrhoea (78.6 %) and watery stools (75.0 %). The prevalence of multi-organ dysfunction
syndrome (10.7 vs 0.40 %) (p = 0.001), hepatic injury (14.3 vs 3.4 %) (p = 0.019), myocardial injury (21.4 vs 6.1 %)
(p = 0.002) and convulsion (21.4 vs 7.2 %) (p = 0.016) was significantly higher in the diarrhoea than no diarrhoea
group. There was no significant difference between the two groups regarding prevalence of death, altered consciousness,
paralysis, central nervous system involvement, or acute respiratory infection.
Conclusions: Most patients with diarrhoea caused by enteroviruses circulating in Guangdong Province in
2009–2012 had mild or moderate gastrointestinal symptoms. Although enterovirus-related diarrhoea caused
additional multi-organ dysfunction syndrome, hepatic injury and myocardial injury in children with HFMD/HA, timely
intervention efficiently reduced disease severity and improved outcome.
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Background
Enteroviruses (EVs) are known to cause hand, foot and
mouth disease/herpangina (HFMD/HA), with numer-
ous epidemics worldwide, including China [1]. Several
complications have been reported in HFMD/HA,
including meningitis, encephalitis, acute flaccid paralysis,
acute cardiopulmonary failure, respiratory infection, myo-
cardial injury, and diarrhoea [2, 3]. Among these complica-
tions in HFMD/HA, diarrhoea is less prominent because of
its low prevalence and generally self-limiting nature. In
China, diarrhoea has generally been neglected or only
mentioned in most studies of HFMD/HA. Moreover,
EV detection is often not included in pathogen surveillance
of diarrhoea; thus, little information on the epidemiology
and clinical features of enterovirus-related diarrhoea is
available in China. Diarrhoea can cause various degrees
of illness, ranging from self-limited changes in stool
consistency to life-threatening complications and even
death. Diarrhoea deserves attention because it is the
third leading cause of death in young children, claiming
millions of lives annually worldwide [4].
Considering the global presence of HFMD/HA, there
is an urgent need to elucidate the clinical characteristics
of enterovirus-related diarrhoea and its impact on HFMD/
HA. Therefore, the purpose of this study was to describe
the clinical features and implications of enterovirus-related
diarrhoea in children with HFMD/HA admitted to
Zhujiang Hospital during 2009–2012.
Methods
Study population and data collection
All cases were inpatients admitted to the Paediatric
Department of Zhujiang Hospital between January 2009
and December 2012. Zhujiang Hospital is an officially
designated tertiary hospital for treatment of HFMD in
Guangzhou City (capital of Guangdong Province, China)
and its neighbouring districts. Anonymous processing of
patient information ensured the privacy of patients, and
the study was approved by the Ethics Committee of
Zhujiang Hospital (Ratification No: ZJYY-2013-YXJYZX-
001). Signed informed consent was obtained from parents
or guardians. Cases were included if they met all of the
inclusion criteria and none of the exclusion criteria. Inclu-
sion criteria were: paediatric inpatients with eruptions or
fever; and real-time fluorescence reverse transcriptase
polymerase chain reaction (RT-PCR) evidence of positive
enterovirus. Exclusion criteria were: medical history of
neurological disease, congenital heart disease or immune
deficiency; or evidence of infection by rotavirus, norovirus,
Shigella, Campylobacter or Salmonella species. Clinical
data for each case were retrospectively reviewed and ex-
tracted from medical records, and patients were assigned
to the diarrhoea or no diarrhoea group, depending on
whether they presented with diarrhoea. Clinical features
were compared between the two groups to explore the
implications of diarrhoea in HFMD/HA.
Stool sample collection and testing
Stool specimens from each case were collected for ex-
traction of RNA and stored at −80 °C. Viral RNAs
were extracted from 140-μl stool samples using the
QIAamp Viral RNA Mini Kit system (Qiagen, Hilden,
Germany). Extracted RNAs were used for real-time
fluorescence RT-PCR and/or the amplification of
partial-length fragments of enterovirus viral protein
(VP)1/5’-untranslated region (UTR). Serotypes of en-
terovirus 71 (EV71) and coxsackievirus 16 (CA16)
were jointly determined by enteroviruses kit, EV71 kit,
and CA16 kit (Shanghai ZJ Bio-Tech Co. Ltd., China).
The other serotypes were determined by sequencing
partial-length fragments of VP1/5’-UTR, as described
previously [5, 6]. The enterovirus serotype was ascer-
tained by performing BLAST analysis along with EV
sequences in GenBank. Each patient with diarrhoea
received routine stool examinations, and samples were
tested for bacterial cultures of Shigella, Campylobacter
and Salmonella species. Routine stool examinations
include assessment of colour, consistency, parasite
ova, white blood cells, red blood cells, occult blood,
transferrin, and rotavirus and norovirus antigens.
Clinical definitions
Diarrhoea was defined as a change in stool consistency,
or defecation ≥3 times/day. The severity of diarrhoea
was assessed by a scoring system based on vomiting, fre-
quency and duration of diarrhoea, electrolyte disturb-
ance, dehydration status, and fever. A total score >11
was classified as serious diarrhoea, and ≤11 as mild diar-
rhoea [7]. Central nervous system (CNS) involvement
referred to the presence of two or more of the following:
vomiting, irritability, myoclonic jerk, convulsion, chan-
ged muscular tension, decreased tendon reflex, head-
ache, and neck stiffness. Patients who also had altered
consciousness, paralysis, or CNS lesions on neuroimag-
ing were considered to have severe CNS involvement.
Acute respiratory infection (ARI) was diagnosed by the
presence of rhinorrhoea and/or cough, and patients with
pneumonia or bronchopneumonia were judged to have
severe (ARI). Myocardial injury was diagnosed based on
laboratory evidence of elevated cTnI, or elevated CK-
MB plus CK-MB/CK > 0.25. cTnI > 0.04 μg/l, ratio of
CK-MB/CK > 0.25 and CK-MB > 44 U/L (2 m–36 m),
CK-MB > 37 U/L (37 m–72 m), or CK-MB > 31 U/L
(>73 m) were considered elevated. Cases with alanine
aminotransferase >40 U/l were considered to have
hepatic injury.
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Statistical analysis
Statistical analysis was performed by SPSS version
13.0 (SPSS, Chicago, IL, USA). Differences between
two groups of continuous variables were analysed by
the independent samples t-test, whereas those of categor-
ical variables were analysed by the χ2 test. All p values
were two-sided, and p < 0.05 was considered statistically
significant.
Results
A total of 1778 EV-related HFMD/HA patients were
admitted to the Paediatric Department of Zhujiang
Hospital during 2009–2012. There were 872 inpatients
and 896 outpatients. Most patients with HFMD/HA
were admitted in April to July, with a peak between May
and June (Fig. 1). There was a shift in the dominant en-
terovirus serotype during 2009–2012: CA16 in 2009,
EV71 in 2010–2011, and other EV serotypes in 2012
(Fig. 1). There was a low prevalence of enterovirus-
related diarrhoea and varied prevalence of different EV
serotypes. Of the 872 inpatients, 804 were eligible for
inclusion in this study, and 28 presented with diarrhoea
(3.5 %). We identified enterovirus serotypes in 767
cases, and the detailed distribution of the serotypes in
the no diarrhoea and diarrhoea groups is shown in
Fig. 2a and b, respectively. Diarrhoea prevalences of
different EV serotypes varied considerably: Echo 14
(100 %), CVA21 (100 %), Echo 2 (50.0 %), CVA9
(33.3 %), CVA10 (9.7 %), CVA4 (6.3 %), CVA6 (4.5 %),
EV71 (2.3 %) and CVA16 (0.6 %).
Severity and gastrointestinal symptoms of enterovirus-related
diarrhoea
Based on the scoring system, the 28 cases of diarrhoea had
a score of 4–17, and 23 cases (82.1 %) scored ≤11. Table 1
shows that most patients with enterovirus-related diarrhoea
had mild gastrointestinal symptoms, as characterised by
high prevalence of no dehydration (82.1 %), short duration
of diarrhoea (78.6 %) and watery stools (75.0 %). Two
patient with diarrhoea caused by EV71 died: one died from
cardiopulmonary failure, and the other from multi-organ
dysfunction syndrome (MODS).
Effect of enterovirus-related diarrhoea on outcomes and
severity of HFMD/HA
There were no significant differences between the diar-
rhoea and no diarrhoea groups for duration of hospital-
isation and prevalence of death, altered consciousness,
paralysis, CNS involvement, severe CNS involvement,
ARI and severe ARI (Table 2). Compared with the no
diarrhoea group, the diarrhoea group had a significantly
higher prevalence of MODS (10.7 vs 0.40 %) (p = 0.001),
hepatic injury (14.3 vs 3.4 %) (p = 0.019), myocardial
injury (21.4 vs 6.1 %) (p = 0.002) and convulsion (21.4 vs
7.2 %) (p = 0.016).
Discussion
Our study demonstrated that most cases of enterovirus-
related diarrhoea (82.1 %) were mild without severe gastro-
intestinal symptoms. Among the 28 cases of diarrhoea,
there was a low prevalence of severe dehydration (14.3 %),
frequent episodes of diarrhoea (≥6/day) (35.7 %), long dur-
ation of diarrhoea (≥6 days) (21.4 %), visible bloody stool
(0 %), frequent vomiting (≥5 episodes/day) (10.7 %) and
long duration of vomiting (≥3 days) (10.7 %). Our study
also showed a low prevalence (3.5 %) of diarrhoea caused
by enteroviruses circulating in Guangdong during
2009–2012. Although enteroviruses are not well known
for causing diarrhoea, some studies have shown them to
be causative agents [8–12]. Some other members of the
Picornaviridae, such as Aichi virus, parechovirus, and
bocavirus, have been recently associated with diarrhoea;
however, only with a small number of cases. Therefore,
there was only a small probability that any of the cases of
Fig. 1 Distribution of HFMD/HA cases caused by EV71, CVA16 and other enteroviruses admitted during 2009–2012
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Fig. 2 a Constituent ratios of EV serotypes in group without diarrhoea. b Constituent ratios of EV serotypes in group with diarrhoea
Zhou et al. BMC Infectious Diseases  (2016) 16:128 Page 4 of 7
diarrhoea in the present study were caused by co-
infection with these viruses and enteroviruses. Rota-
virus, norovirus, and Shigella have been reported as
major causative pathogens of diarrhoea in Guangdong
Province and its neighbouring districts [13–16]. Although
we did not perform comprehensive tests to exclude all
possible cofactors of diarrhoea, it is reasonable to suggest
that enteroviruses were responsible for most of the cases
since they were all negative for major potential diarrhoea-
related pathogens.
Enteroviruses are pathogens that can invade and re-
produce in intestinal cells and induce severe inflam-
mation in human intestinal epithelial cells [17–19].
According to the pathogenic mechanisms proposed by
Navaneethan and Giannella, enterovirus-related diar-
rhoea is initiated by inflammation involving activation
of cytokines and inflammatory mediators [20]. EV71
and CVA6 were the two serotypes that claimed more
than half of diarrhoea cases (15/28), the diarrhoea preva-
lences of different EV serotypes varied considerably: Echo
14 (100 %), CVA21 (100 %), Echo 2 (50.0 %), CVA9
(33.3 %), CVA10 (9.7 %), CVA4 (6.3 %), CVA6 (4.5 %),
EV71 (2.3 %) and CVA16 (0.6 %). Although no particular
serotype of enterovirus is especially associated with diar-
rhoea, previous studies have suggested that some serotypes
of echovirus and coxsackievirus B are more likely to cause
diarrhoea [10–12, 21, 22], which is similar to our results.
Enteroviruses are generally not listed as potential patho-
gens for diarrhoea, which leads to limited information
about enterovirus-related diarrhoea, and aetiological mis-
diagnosis. Therefore, physicians should consider enterovi-
ruses as potential pathogens when treating diarrhoea,
especially for cases admitted during times of seasonal en-
terovirus circulation. Moreover, more studies should be
carried out to elucidate the discrepancies and clinical fea-
tures of diarrhea caused by different serotypes of entero-
virus due to the extreme lack of such knowledge.
Enterovirus-related diarrhoea did not did not exert
substantial influence on the severity of HFMD/HA in
patients who received appropriate and timely medical
intervention. No difference was observed between the
diarrhoea and no diarrhoea groups regarding duration of
hospitalisation and prevalence of death, CNS involve-
ment, severe CNS involvement, paralysis, altered con-
sciousness, ARI and severe ARI. Although the diarrhoea
group had significantly higher prevalence of MODS
(10.7 vs 0.40 %), hepatic injury (14.3 vs 3.4 %), myocar-
dial injury (21.4 vs 6.1 %) and convulsion (21.4 vs 7.2)
than no diarrhoea group, all of these manifestations were
short term and reversible with treatment. The limited
influence of diarrhoea on severity of HFMD/HA was
largely due to the following factors: the mild or moderate
nature of most diarrhoea, without severe and long-term
dehydration; appropriate and timely medical intervention;
the inflammatory mechanism of enterovirus-related diar-
rhoea; and inability of enterovirus particles and proinflam-
matory cytokines to cross the blood–brain barrier in most
conditions. Evasion and modulation of the gastrointestinal
defence systems of the host are essential for pathogens
causing infectious diarrhoea [20]. Thus, it is reasonable to
assume that higher levels of cytokines and inflammatory
mediators will be produced in HFMD/HA patients with
Table 1 Clinical presentations of 28 enterovirus-related HFMD/HA
inpatients with diarrhoea
Characters N (%)
Age (months) 28.7 ± 17.7
































Occult blood in stool 4 (14.3)
Mild diarrhoea (score ≤ 11) 23 (82.1)
Severe diarrhoea (score > 11) 5 (17.9)
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than without diarrhoea. These higher levels can cause
increased prevalence of hepatic injury, myocardial injury
and MODS in HFMD/HA patients with diarrhoea. In our
study, most cases of diarrhoea (82.1 %) presented without
dehydration, and timely hospital treatment abolished
dehydration when it did occur. Therefore, it was inflam-
mation rather than haemodynamic disturbance caused by
dehydration that was responsible for the differences
between the diarrhoea and no diarrhoea groups. Because
MODS was initiated by inflammation, there was no sig-
nificant increase in mortality in the diarrhoea group when
patients received timely medical intervention. The excep-
tionally high prevalence of convulsion in the diarrhoea
group was largely because convulsion, unlike other neuro-
logical manifestations, can be induced in young children by
mere dehydration or electrolyte imbalance. The absence of
any substantial increase in prevalence of CNS involvement,
severe CNS involvement and paralysis in HFMD/HA with
diarrhoea was a relief for such patients.
Some limitations may exist because our study was a
retrospective observation based on the enterovirus sero-
types that were circulating in Guangdong province during
2009–2012. Moreover, the limited number of diarrhoea
cases and other possible co-infections may also have
biased the results. Intensive treatment administered dur-
ing hospitalization also limited the natural progression of
diarrhoea and even prevented its impact on the severity of
HFMD/HA. Therefore, more studies should be carried
out to elucidate the characteristics of enterovirus-related
diarrhoea and their implications in HFMD/HA.
Conclusions
From 2009 to 2012, patients with diarrhoea caused by
circulating enteroviruses had mostly mild or moderate
gastrointestinal symptoms. Timely intervention reduced
disease severity and improved outcome in children with
HFMD/HA. As a result of its mild severity and being
initiated by inflammation, enterovirus-related diarrhoea
did not exert a major influence on severity or outcome
in HFMD/HA inpatients in Guangdong, China, during
2009–2012.
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Table 2 Comparisons of clinical features between patients with and without diarrhoea
Characteristics Diarrhoea (%) (n = 28) No diarrhoea (%) (n = 776) P
Demographic
Diarrhoea (months) 18.3 ± 21.2 29.1 ± 17.6 0.015
Male-to-female ratio 1.55:1 2.00:1 0.506
Fever ≥ 39 °C 16 (57.1) 459 (59.1) 0.832
Fever duration ≥ 3 days 20 (71.4) 446 (57.5) 0.142
Elevated ALT 4 (14.3) 23/675 (3.4) 0.019
Elevated myocardial enzyme 6 (21.4) 30/703 (6.1) 0.002
Convulsion 6 (21.4) 56 (7.2) 0.016
Altered consciousness 4 (14.3) 65 (8.5) 0.291
Severe CNS involvement 4 (14.3) 86 (11.1) 0.543
CNS involvement 12 (42.9) 233 (30.0) 0.147
Severe ARI 5 (17.9) 99 (12.8) 0.393
ARI 11 (39.3) 244 (31.4) 0.410
MODS 3 (10.7) 3 (0.40) 0.001
Paralysis 0 (0.0) 28 (3.6) 0.619
Mortality 2 (7.1) 12 (1.5) 0.082
Duration of hospitalization (days) 6.0 ± 2.7 6.3 ± 4.2 0.792
Note. ALT alanine aminotransferase, ARI acute respiratory infection, CNS central nervous system, MODS multi-organ dysfunction syndrome
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